By Core Insurance SolutionsOctober 6, 2026

Tiering Exception Toolkit: U.S. Medicare Prescriber Form & 72 Hour Rule

A Medicare Part D tiering exception can lower what you pay for a prescription drug when your prescriber confirms that the lower-cost, preferred alternatives either don’t work for you or cause adverse effects. You, your appointed representative, or your prescriber can file the request, but it only moves forward once your plan receives a prescriber’s supporting statement. Specialty-tier drugs don’t qualify, and brand-name drugs can’t drop to a generic copay. Plans must generally decide as expeditiously as the enrollee’s health requires following receipt of that statement, but no later than 72 hours.

TL;DR:

A valid tiering exception requires a prescriber’s statement demonstrating that preferred lower-tier drugs are less effective or cause adverse effects.

Filing can be done by you, a representative, or your prescriber, with written requests on the CMS form being the most reliable.

The prescriber’s statement must specify the diagnosis, prior treatments with outcomes, and a conclusion that the lower-tier options are inappropriate.

Plans must decide within 72 hours after receiving the supporting statement; missed deadlines lead to automatic escalation to the independent review entity.

Specialty-tier drugs and requests to pay a brand-name at a generic copay are excluded from eligibility for tiering exceptions.

Core Insurance SolutionsGet Support With Medicare ClaimsCore Insurance Solutions helps seniors review coverage, manage prescription costs, and receive advocacy when Medicare claims become difficult.Visit Core Insurance Solutions

What Counts as a Valid Tiering Exception
Who Can File and How to Submit Your Request
What the Prescriber’s Statement Must Say
Timeline, Notices, and What to Expect From Your Plan
Limits, Exclusions, and Special Cases
If Your Tiering Exception Is Denied
Checklist and Prescriber Statement Template
Why Documentation Detail Changes the Outcome
How We Help With Part D Tiering Exceptions
FAQ
Sources

What Counts as a Valid Tiering Exception

A Medicare Part D plan can only grant a tiering exception when your prescriber shows that the drug is medically necessary because the preferred, lower-tier alternatives would be less effective for you or would cause an adverse reaction. This is the legal standard plans use under federal rules, and it is a clinical judgment, not a convenience request. According to CMS, the exception process exists specifically to move a non-preferred drug to a lower cost-sharing tier when that medical necessity test is met.

A tiering exception is often confused with other coverage tools, but they solve different problems:

Tiering exception: asks the plan to charge you less for a drug that is already on the formulary, just on a higher cost-sharing tier.
Formulary exception: asks the plan to cover a drug that isn’t on the formulary at all.
Prior authorization: a plan requirement you must satisfy before a drug is covered at any tier, unrelated to cost-sharing level.
Step therapy: a plan rule requiring you to try one drug before another is covered, which can sometimes be bypassed with its own exception process.

Scenarios that typically meet the medical necessity standard include a patient who already tried the preferred statin and developed muscle pain severe enough to stop treatment, a patient whose blood pressure remained uncontrolled on two formulary-preferred medications, or someone with a documented allergic reaction to an ingredient in the lower-tier drug. The common thread in each case is a paper trail: specific drugs tried, specific dates, and a specific clinical outcome. The regulatory language governing this standard sits in § 423.568 of the eCFR, which also sets the clock plans must follow once they receive supporting evidence.

Who Can File and How to Submit Your Request

You don’t have to be the one who fills out the paperwork. Under CMS rules, a tiering exception request can come from you, a representative you’ve appointed, or your prescribing clinician directly, and plans must accept requests by phone or in writing.

Confirm the drug’s tier and plan contact information by checking your plan’s formulary document or member portal.
Ask your prescriber’s office to prepare a supporting statement that addresses medical necessity in writing.
Download and complete the Model Coverage Determination Request Form, which CMS designed to capture everything a plan needs in one document.
Attach prior therapy records, including drug names, start and stop dates, and outcomes or side effects.
Submit by fax, mail, or your plan’s online portal, and keep a copy of everything sent.
If you call instead, write down the date, the representative’s name, and a reference number for your records.

Pro Tip: Even if your plan accepts verbal requests, a written submission using the CMS model form reduces the chance that a reviewer asks for missing information, which restarts the clock.

The most reliable path is usually the written one. A phone-only request can work when you’re pressed for time, but it leaves more room for the plan to say a required piece of information never arrived. Gathering your drug details, dates of prior therapies, and contact information before you call or mail anything saves a second round of back-and-forth with your plan.

What the Prescriber’s Statement Must Say

The prescriber’s supporting statement is the single piece of paperwork that determines whether your request even starts moving. Without it, your plan has no obligation to begin the 72-hour review clock described under § 423.568.

A strong statement typically includes:

Your diagnosis, stated plainly and tied to the drug being requested.
Each preferred drug you tried, with names and the dates you started and stopped.
The specific outcome of each prior therapy, such as inadequate symptom control, a lab value that didn’t improve, or an adverse reaction.
Objective findings, like blood pressure readings, A1c levels, or imaging results, whenever they support the clinical picture.
A direct conclusion statement, explicitly saying the preferred alternatives are less effective for this patient or caused adverse effects.

A model sentence a clinician can adapt: “Patient was treated with [preferred drug] from [date] to [date] and discontinued due to [adverse effect/inadequate response], as documented by [lab value/clinical note]; [requested drug] is medically necessary because the preferred alternatives on this plan’s formulary are not appropriate for this patient.”

Pro Tip: Vague language like “patient did not tolerate” invites a denial. Naming the drug, the date range, and the specific adverse effect or lab value gives the reviewer nothing to question.

Keep in mind that even a flawless statement cannot overcome certain built-in restrictions. Specialty-tier drugs and requests to pay a generic copay for a brand-name drug fall outside what a tiering exception can achieve, a limit covered in more detail below.

Timeline, Notices, and What to Expect From Your Plan

Once your plan receives the prescriber’s supporting statement, the clock starts. Plans must notify you and your prescriber within 72 hours of receiving that statement, a timeframe set under § 423.568 of the eCFR. That detail matters because the 72 hours doesn’t begin on the day you call the plan. It begins when the supporting statement itself lands in the plan’s hands.

What this means in practice:

No statement, no clock. Filing a request without the prescriber’s statement is one of the most common reasons decisions stall.
Missed deadlines trigger an automatic escalation. If the plan fails to decide within the required timeframe, it must forward your case to the Independent Review Entity (IRE) within 24 hours, and the missed deadline itself counts as an adverse determination.
Follow up proactively. A short call to your prescriber’s office a day or two after your plan contacts them, confirming the statement was sent, catches most delays before they become a missed deadline.
Approval changes your cost-sharing immediately. If your tiering exception is approved, your plan reassigns the drug’s cost-sharing to the lowest applicable preferred tier for the remainder of your plan year.

Staying ahead of the paperwork is worth the effort. The entire review runs on a tight clock, and a one-day delay in sending a supporting statement can push your decision date back by the same amount.

Limits, Exclusions, and Special Cases

Tiering exceptions solve a specific problem, and they come with boundaries that are worth knowing before you file.

Specialty-tier drugs are excluded. Federal rules under § 423.578 of the eCFR allow plans to exclude drugs on the specialty tier from the tiering exception process entirely, so check your formulary tier designation before filing.
Brand-at-generic pricing isn’t available. A tiering exception cannot get you a brand-name drug priced at a generic copayment, even when the brand is medically necessary.
Quantity limits and step therapy are separate hurdles. Clearing a tiering exception doesn’t automatically waive a quantity limit or a step therapy requirement attached to the same drug. Those need their own exception request if they apply.
Mid-year tier changes require a fresh look. If your plan moves a drug you’re already taking to a higher tier mid-year, you can file a new tiering exception referencing your prior coverage and the dates you’ve been stable on that medication.

When a drug falls into one of these excluded categories, manufacturer patient assistance programs or a formulary exception request aimed at a different coverage category are sometimes the more realistic route. A broker or pharmacist familiar with your specific plan can help you figure out which lever actually applies to your situation.

If Your Tiering Exception Is Denied

A denial isn’t the end of the process. Medicare built a five-level appeals ladder specifically for situations like this.

Redetermination (Level 1): File with your plan within 60 days of the denial notice, ideally with an updated prescriber statement that adds any new clinical detail.
Reconsideration by an Independent Review Entity (Level 2): If your plan upholds the denial, the IRE reviews the case independently, and you can request this escalation directly.
Administrative Law Judge hearing (Level 3): Available once the dollar amount in dispute meets the required threshold, and your prescriber’s documentation again matters here.
Medicare Appeals Council review (Level 4): A further review if the Administrative Law Judge decision doesn’t resolve the issue.
Federal District Court review (Level 5): The final level, reserved for cases meeting a minimum amount in controversy.

At each level, the strongest move is adding new objective evidence rather than repeating the same statement that already failed to persuade. Updated lab values, a more detailed adverse-effect description, or documentation of a therapy you tried since your last filing all carry weight. If you believe your plan mishandled the timeline itself, such as failing to forward your case to the IRE after a missed deadline, filing a complaint with CMS directly is appropriate. Readers dealing with denials tied to other high-cost medications, like GLP-1 drugs, can find a parallel walkthrough of the appeals process in this guide on appealing a denied GLP-1 prescription, which covers similar documentation strategies.

Checklist and Prescriber Statement Template

Filing a clean request the first time saves weeks. Here’s what to have ready before you or your prescriber submits anything.

Patient checklist:

Drug name, strength, and the tier it currently sits on.
Plan name and the fax number or portal link for coverage determination requests.
A list of every preferred drug tried, with start and stop dates.
Contact information for both your prescriber’s office and your plan’s member services line.
A completed CMS Model Coverage Determination Request Form.

Prescriber statement template (adapt the brackets to your patient):

Patient has a diagnosis of [condition]. Patient was treated with [preferred drug 1] from [date] to [date] and [preferred drug 2] from [date] to [date], both discontinued due to [adverse effect or lack of efficacy, with supporting lab value or clinical note]. Based on this treatment history, [requested drug] is medically necessary because the plan’s preferred alternatives are not appropriate for this patient.

A short phone script helps too: “I’m calling to confirm you received the supporting statement for a tiering exception request for [patient name], submitted on [date]. Can you tell me the reference number and the expected decision date?”

This is exactly the kind of paperwork we help clients organize every week. Our prescription cost optimization service walks through your current formulary, flags drugs sitting on higher tiers than necessary, and helps you and your prescriber’s office put together a request that holds up on the first submission. For readers who want the fuller picture of how Part D formularies and tiers work before filing anything, our guide to navigating prescription drug plans covers the basics in plain language.

Why Documentation Detail Changes the Outcome

In experience helping clients work through Part D paperwork, the single most common reason a tiering exception stalls isn’t a weak clinical case. It’s a statement that says “didn’t work” without saying why, when, or compared to what. Plans aren’t being difficult when they ask for more. They’re following a standard that requires specific proof, and a vague note gives a reviewer nothing to approve.

The fix is rarely complicated. A phone call connecting a patient’s pharmacy history with a prescriber’s clinical notes, made before the request goes out rather than after a denial comes back, resolves most cases. That coordination is often what separates a 72-hour approval from a two-month appeal.

Tiering exception coordination and response timelines

How We Help With Part D Tiering Exceptions

Lowering your drug copayment through a tiering exception works best when someone is coordinating the paperwork between you, your prescriber, and your plan, and that coordination is where we spend most of our time. We built our approach around the exact friction points that slow these requests down.

Core Insurance Solutions

Here’s what our support typically includes:

Prescription cost optimization to identify which of your current drugs sit on a higher tier than necessary.
Claims advocacy to follow up with your plan and prescriber’s office so paperwork doesn’t sit untouched.
Annual policy audits that catch formulary and tier changes before they hit your wallet.
Local Part D plan support for Lakeland-area enrollees comparing coverage options.

An initial consult starts with a review of your current plan and medication list, a look at whether a tiering exception or a different coverage route fits your situation, and direct help drafting the request alongside your prescriber’s office. Visit our Part D services page to get started, or watch our Medicare 101 webinar replay for a broader look at how Part D coverage decisions fit into your overall Medicare plan.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

FAQ

What are the rules for Medicare tier exceptions?

A tiering exception requires your prescriber to submit a supporting statement showing that preferred, lower-tier drugs are either less effective for you or cause adverse effects, as outlined by CMS. Specialty-tier drugs aren’t eligible, and the exception cannot reduce a brand-name drug to a generic copayment.

What is the income limit to avoid higher Medicare premiums?

Income-related monthly adjustment amounts for Medicare premiums are based on your modified adjusted gross income from two years prior and are set annually by CMS, separate from the tiering exception process. Check your specific income bracket directly on Medicare or with your plan, since thresholds and adjustments change each year.

What are the five things that Medicare will not cover in 2026?

Medicare coverage exclusions vary by category and by whether you have Original Medicare, a Medicare Advantage plan, or a Part D plan, and a single universal list for every beneficiary doesn’t exist. For prescription drugs specifically, Part D plans generally exclude drugs for weight loss, fertility, and cosmetic purposes, among other categories; check your plan’s formulary document for the exact exclusions that apply to you.

How do I get a tier exception approved?

The strongest approvals come from a prescriber’s statement that names each preferred drug you tried, the exact dates, and a specific clinical outcome like an adverse effect or lab value, submitted along with the CMS Model Coverage Determination Request Form. Once your plan receives that statement, it generally must decide within 72 hours under federal timing rules.

Sources

These official resources cover everything referenced above, from filing a request to understanding the regulatory timeline.